Non-Viral Vector Delivery

Non-viral delivery platforms offer flexibility and rapid innovation but often require custom formulation, characterization, and scale-up strategies to reach GMP readiness.

Artis supports non-viral delivery programs through integrated formulation development, analytics, and manufacturing planning.

Formulation and Delivery Optimization Model

Our teams develop and optimize nanoparticle and vesicle systems with manufacturability, stability, and analytical measurability in mind. Coordinated formulation, analytical, and GMP planning reduces downstream rework and supports evolving platform needs.